• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Consumables - Market size and forecast 2020-2025
o Instruments - Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o APAC - Market size and forecast 2020-2025
o South America - Market size and forecast 2020-2025
o MEA - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Avance Biosciences Inc.
o Becton Dickinson and Co.
o Fluidigm Corp.
o JN Medsys Pte. Ltd.
o Merck and Co. Inc.
o QIAGEN NV
o Stilla Technologies Inc.
o Sysmex Asia Pacific Pte Ltd.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Consumables - Market size and forecast 2020-2025 ($ million)
• 24: Consumables - Year-over-year growth 2020-2025 (%)
• 25: Instruments - Market size and forecast 2020-2025 ($ million)
• 26: Instruments - Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2020-2025 ($ million)
• 32: North America - Year-over-year growth 2020-2025 (%)
• 33: Europe - Market size and forecast 2020-2025 ($ million)
• 34: Europe - Year-over-year growth 2020-2025 (%)
• 35: APAC - Market size and forecast 2020-2025 ($ million)
• 36: APAC - Year-over-year growth 2020-2025 (%)
• 37: South America - Market size and forecast 2020-2025 ($ million)
• 38: South America - Year-over-year growth 2020-2025 (%)
• 39: MEA - Market size and forecast 2020-2025 ($ million)
• 40: MEA - Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Avance Biosciences Inc. - Overview
• 50: Avance Biosciences Inc. - Product and service
• 51: Avance Biosciences Inc. - Key offerings
• 52: Avance Biosciences Inc. - Key customers
• 53: Avance Biosciences Inc. - Segment focus
• 54: Becton Dickinson and Co. - Overview
• 55: Becton Dickinson and Co. - Business segments
• 56: Becton Dickinson and Co. - Key offerings
• 57: Becton Dickinson and Co. - Key customers
• 58: Becton Dickinson and Co. - Segment focus
• 59: Bio-Rad Laboratories, Inc - Overview
• 60: Bio-Rad Laboratories, Inc - Business segments
• 61: Bio-Rad Laboratories, Inc - Key offerings
• 62: Bio-Rad Laboratories, Inc - Key customers
• 63: Bio-Rad Laboratories, Inc - Segment focus
• 64: Fluidigm Corp. - Overview
• 65: Fluidigm Corp. - Business segments
• 66: Fluidigm Corp. - Key offerings
• 67: Fluidigm Corp. - Key customers
• 68: Fluidigm Corp. - Segment focus
• 69: JN Medsys Pte. Ltd. - Overview
• 70: JN Medsys Pte. Ltd. - Product and service
• 71: JN Medsys Pte. Ltd. - Key offerings
• 72: JN Medsys Pte. Ltd. - Key customers
• 73: JN Medsys Pte. Ltd. - Segment focus
• 74: Merck and Co. Inc. - Overview
• 75: Merck and Co. Inc. - Business segments
• 76: Merck and Co. Inc. - Key offerings
• 77: Merck and Co. Inc. - Key customers
• 78: Merck and Co. Inc. - Segment focus
• 79: QIAGEN NV - Overview
• 80: QIAGEN NV - Business segments
• 81: QIAGEN NV - Key offerings
• 82: QIAGEN NV - Key customers
• 83: QIAGEN NV - Segment focus
• 84: Stilla Technologies Inc. - Overview
• 85: Stilla Technologies Inc. - Product and service
• 86: Stilla Technologies Inc. - Key offerings
• 87: Stilla Technologies Inc. - Key customers
• 88: Stilla Technologies Inc. - Segment focus
• 89: Sysmex Asia Pacific Pte Ltd. - Overview
• 90: Sysmex Asia Pacific Pte Ltd. - Product and service
• 91: Sysmex Asia Pacific Pte Ltd. - Key offerings
• 92: Sysmex Asia Pacific Pte Ltd. - Key customers
• 93: Sysmex Asia Pacific Pte Ltd. - Segment focus
• 94: Thermo Fisher Scientific Inc. - Overview
• 95: Thermo Fisher Scientific Inc. - Business segments
• 96: Thermo Fisher Scientific Inc. - Key offerings
• 97: Thermo Fisher Scientific Inc. - Key customers
• 98: Thermo Fisher Scientific Inc. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

Companies Mentioned
. Avance Biosciences Inc.
. Becton Dickinson and Co.
. Bio-Rad Laboratories
. Inc
. Fluidigm Corp.
. JN Medsys Pte. Ltd.
. Merck and Co. Inc.
. QIAGEN NV
. Stilla Technologies Inc.
. Sysmex Asia Pacific Pte Ltd.
. Thermo Fisher Scientific Inc.